<p>The epidemiology of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and <i>Treponema pallidum</i> among Cameroonian blood donors was addressed in this study. This prospective study was conducted from December 2021 to February 2022 at the Blood Transfusion Centre (BTC) of Douala Laquintinie Hospital. Blood bags were screened for HBV, HCV, HIV, and <i>T. pallidum</i> using standard tests. Donors’ medical records and the BTC database were consulted to collect data of interest. A total of 1,728 blood bags were included in the study; among them, 805 (46.6%) were from first-time donors. The overall prevalence of TTIs was 19.6%. HCV infection (9.3%) was the most frequent recorded TTI. Co-infections (3.2%) were mainly caused by HCV + <i>T. pallidum</i> (1.2%) and HCV + HIV (0.8%). The risk of TTI was higher in donors aged 35–45 years (aOR = 1.62, <i>p</i> = 0.04) and ≥ 45 years (aOR = 2.59, <i>p</i> = 0.0009). A high education level and being a family donor were protective factors for TTIs, HIV, and <i>T. pallidum</i>. Our findings will contribute to ongoing efforts by the government of Cameroon to improve the safety of transfusion-related systems and strategies at both the regional and national levels.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Investigating the prevalence and determinants of HIV, HBV, HCV, and Treponema pallidum among blood donors in Douala, Cameroon

  • Gildas Ingrid Deutou Hogoue,
  • Christiane Medi Sike,
  • Kikie Josiane Essola,
  • Zaïna Polyclaire Ngansop Tchapdjouo,
  • Steve Armand Nzogang Tchonet,
  • Elisee Libert Embolo Enyegue,
  • Loick Pradel Kojom Foko,
  • Martin Luther Koanga Mogtomo

摘要

The epidemiology of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and Treponema pallidum among Cameroonian blood donors was addressed in this study. This prospective study was conducted from December 2021 to February 2022 at the Blood Transfusion Centre (BTC) of Douala Laquintinie Hospital. Blood bags were screened for HBV, HCV, HIV, and T. pallidum using standard tests. Donors’ medical records and the BTC database were consulted to collect data of interest. A total of 1,728 blood bags were included in the study; among them, 805 (46.6%) were from first-time donors. The overall prevalence of TTIs was 19.6%. HCV infection (9.3%) was the most frequent recorded TTI. Co-infections (3.2%) were mainly caused by HCV + T. pallidum (1.2%) and HCV + HIV (0.8%). The risk of TTI was higher in donors aged 35–45 years (aOR = 1.62, p = 0.04) and ≥ 45 years (aOR = 2.59, p = 0.0009). A high education level and being a family donor were protective factors for TTIs, HIV, and T. pallidum. Our findings will contribute to ongoing efforts by the government of Cameroon to improve the safety of transfusion-related systems and strategies at both the regional and national levels.